Archon Partners’s Johnson & Johnson JNJ Stock Holding History

Archon Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-69,000	Closed	-$11.4M	–	41
2023 Q2	$11.4M	Buy	69,000 +11,000	+19%	+$1.78M	1.71%	21
2023 Q1	$8.99M	Buy	+58,000	New	+$9.37M	1.5%	24
2019 Q1	–	Sell	-56,600	Closed	-$7.3M	–	59
2018 Q4	$7.3M	Buy	+56,600	New	+$7.9M	1.82%	28

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Archon Partners's JNJ Position: Q3 2023 in Review

Archon Partners sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 69,000 shares — an estimated $11.4M sold.

Archon Partners first reported a position in JNJ in Q4 2018 and held it in 3 quarters. The position peaked at $11.4M in Q2 2023. 3,679 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

Archon Partners reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
Archon Partners sold 69,000 Johnson & Johnson shares in Q3 2023, an estimated $11.4M.
Archon Partners first reported a position in Johnson & Johnson in Q4 2018 and held it in 3 quarters.
Archon Partners's Johnson & Johnson position peaked at $11.4M in Q2 2023.
3,679 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on Archon Partners's 13F filing for Q3 2023, filed 14 Nov 2023.